1don MSN
Promising new therapy developed for most common form of bone cancer in children and young adults
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
But the injectable drug romiplostim (Nplate) can effectively prevent chemo from causing thrombocytopenia, by boosting bone ...
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication ...
Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
For the osteoporosis in my hip, I took alendronate for five years, but it did not stop the bone loss. I am now on Prolia, ...
Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results